|
Dr. Muna Al Maslamani
Dr. Muna Al Maslamani is the Medical Director of Communicable Disease Center and Assistant Head of Infectious Diseases Division–Medicine Department at Hamad General Hospital, Hamad Medical Corporation, Qatar. She is a Senior Consultant in Transplant Infectious Diseases for the Division. Dr. Muna added an Msc-HealthCare Management (RCSI-Bahrain) and IHI Fellowship (Institute of Healthcare Improvement & Hamad Medical Corporation) in 2015 to her list of educational achievements which includes MBBS (KFU-KSA,1997), Certification Arab Board Medical Specialization-Internal Medicine (CABMS-Internal Medicine-Syria,2002), Certification of Complete HMC-Infectious Disease Fellowship Training Program (HMC-IDFTP-Qatar,2006). Apart from clinical responsibilities, she also holds various administrative and academic positions in and outside HMC, namely Vice Chairperson for Quality and Patient Safety–Medicine, Fellowship Program Director for Infectious Diseases, Associate Program Director for Transitional Year and also as Assistant Professor of Clinical Medicine in Weill Cornell Medicine-Qatar (WCM-Q). In 2010, Dr. Muna was appointed Chairperson of Medical Research Committee and Vice-Chairperson of Medical Research Center.
Dr. Muna was elected as Assistant Chairperson-Department of Internal Medicine from October 2006 till September 2012, then Acting Chairperson Department of Internal Medicine till December 2012. She is part of various hospital committees and a member of American College of Physicians, Infectious Diseases Society of America, Transplant Infectious Diseases Society and Immunocompromised Host Society. Dr. Muna is a great role model who is committed to improving the quality of patient care and takes necessary steps to motivate others in doing the same. Her role as a sponsor for the Clinical Care Improvement Training Program (CCITP) of Quality Division and her involvement in IHI Best Care Always Campaign has produced 40 Quality Improvement Projects till date. She received various Intramural and External research grants and was able to partner with international researchers in conducting clinical research and published 53 publications till date. In the past five years, she received 3 major grants from QNRF’s NPRP cycle totaling $2,308,120. Several Leadership and Service awards which she received for her achievements are an evidence of her passion and commitment towards work and patients. She is a regular speaker and moderator at many Infectious Diseases Conferences.
|
|
|
|